Hiperkalsemi

Fehrenbach M, Herring S. Illustrated Anatomy of he Head and Neck.5nd ed. eBook ISBN: 9780323429559. 2015.

Fraser WD. Hyperparathyroidism. Lancet. 2009 Jul 11;374(9684):145-58.

Tjahjono R, Nguyen K, Phung D, et al. Methods of identification of parathyroid glands in thyroid surgery: A literature review. ANZ J Surg.2021;91(9):1711-1716

Carrick AI, Costner HB. Rapid Fire: Hypercalcemia. Emerg Med Clin North Am. 2018; 36 (3):549-555.

Minisola S, Pepe J, Piemonte S, et al. The diagnosis and management of hypercalcaemia. BMJ. 2015;350:h2723. doi:10.1136/bmj.h2723

6.Wagner J, Arora S. Oncologic Metabolic Emergencies. Hematol Oncol Clin North Am. 2017; 31(6):941-957.

Song L. Calcium and Bone Metabolism Indices. Adv Clin Chem. 2017;82:1-46.

Manual M. Hypercalcemia. Archived from the original on July 13, 2017. Retrieved June 10, 2017.

Afzal M, Kathuria P. Familial Hypocalciuric Hypercalcemia. Free Books & Documents. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Van der Plas WY, Noltes ME, van Ginhoven TM, et al. Secondary and Tertiary Hyperparathyroidism: A Narrative Review. Scand J Surg. 2020;109(4):271-278.

Alfieri C, Mattinzoli D, Messa P. Tertiary and Postrenal Transplantation Hyperparathyroidism. Endocrinol Metab Clin North Am. 2021;50(4):649-662.

Hu MI. Hypercalcemia of Malignancy. Endocrinol Metab Clin North Am. 2021;50(4):721-728

Lim K, Thadhani R. Vitamin D Toxicity. J Bras Nefrol. 2020;42(2):238-244.

Mei X, Zeng J, Dai WX, et al. Prevalence of hyperthyroidism with hypercalcemia in Xindu district and the efficacy of vitamin D3 treatment in these patients: a randomized trial. Ann Palliat Med.2021;10(9):9640-9.

Díaz-Roldán J, Franch-Arcas G, Ruiz-Luque V. Hypercalcemia and bulky primary adrenal non-Hodgkin lymphoma: A case report. Med Clin (Barc),2021;157(12):595-6

Gandhi A, Mortensen M, Sunny S, et al. Immobilization-induced hypercalcemia in a patient with renal failure. Endocrinol Diabetes Metab Case Rep. 2021;2021:21-0086

Ali R, Patel C. Milk-Alkali Syndrome. Free Books & Documents. PMID: 32491432 Bookshelf ID: NBK557500. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Borgan SM, Khan LZ, Makin V. Hypercalcemia and vitamin A: A vitamin to keep in mind. Cleve Clin J Med. 2022;89(2):99-105

Garam N, Tislér A, Pethő Á, et al. Hypercalcemia and renal insufficiency – where can we start? Orv Hetil.2021;162(13):514-8.

Saponaro F. Rare Causes of Hypercalcemia. Endocrinol Metab Clin North Am. 2021;50(4):769-79.

Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab.2018;103(11):3993-4004.

Khoury N, Carmichael KA. Evaluation and therapy of hypercalcemia. Mo Med 2011;108:99.

Simm PJ, Biggin A, Zacharin MR, et al. APEG Bone Mineral Working Group.Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health.2018;54(3):223-33.

LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: anunproven yet common practice. Ann Intern Med 2008; 149:259.

Walker J. Diagnosis and management of patients with hypercalcaemia. Nurs Older People. 2015;27(4):22-6.

Bhangu JS, Selberherr A, Brammen L, et al. Efficacy of calcium excretion and calcium/creatinineclearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Head Neck,2019;41(5):1372-8.

Berenson JR. Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol,2002;29(6):12-8.

Hu MI, Glezerman IG, Leboulleux S, et al. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab 2014; 99(9):3144–52.

Torres PU. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronickidney disease. J Ren Nutr 2006; 16(3):253–8.

Uludağ M, Aygün N. Primer Hiperparatiroidi: Klinik ve Biyokimyasal Bulguların Güncel Durumu. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 50, Sayı: 3, 2016 DOI: 10.5350/SEMB.20160724041035

Assadi F. Hypercalcemia: an evidence-based approach to clinical cases. Iran J Kidney Dis 2009;3: 71-9

Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment Endocr Rev. 2016; 37(5): 521–47.

Ritz E, Matthias S, Siedel A. Distributed calcium metabolism in renal failure – pathogenesis and therapeutic strategies. Kidney International 1994;37-42.

Zajı'ckova K, Dvora'kova M, Moravcová J, et al. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up Physiol Res. 2020;69:321-8.

Nazia M. Sadiq NM, Naganathan S, et al. Hypercalcemia Treasure Island (FL): StatPearls Publishing; 2022 Jan Bookshelf ID: NBK430714PMID: 28613465

Fehrenbach M, Herring S. Illustrated Anatomy of he Head and Neck.5nd ed. eBook ISBN: 9780323429559. 2015.

Fraser WD. Hyperparathyroidism. Lancet. 2009 Jul 11;374(9684):145-58.

Tjahjono R, Nguyen K, Phung D, et al. Methods of identification of parathyroid glands in thyroid surgery: A literature review. ANZ J Surg.2021;91(9):1711-1716

Carrick AI, Costner HB. Rapid Fire: Hypercalcemia. Emerg Med Clin North Am. 2018; 36 (3):549-555.

Minisola S, Pepe J, Piemonte S, et al. The diagnosis and management of hypercalcaemia. BMJ. 2015;350:h2723. doi:10.1136/bmj.h2723

6.Wagner J, Arora S. Oncologic Metabolic Emergencies. Hematol Oncol Clin North Am. 2017; 31(6):941-957.

Song L. Calcium and Bone Metabolism Indices. Adv Clin Chem. 2017;82:1-46.

Manual M. Hypercalcemia. Archived from the original on July 13, 2017. Retrieved June 10, 2017.

Afzal M, Kathuria P. Familial Hypocalciuric Hypercalcemia. Free Books & Documents. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Van der Plas WY, Noltes ME, van Ginhoven TM, et al. Secondary and Tertiary Hyperparathyroidism: A Narrative Review. Scand J Surg. 2020;109(4):271-278.

Alfieri C, Mattinzoli D, Messa P. Tertiary and Postrenal Transplantation Hyperparathyroidism. Endocrinol Metab Clin North Am. 2021;50(4):649-662.

Hu MI. Hypercalcemia of Malignancy. Endocrinol Metab Clin North Am. 2021;50(4):721-728

Lim K, Thadhani R. Vitamin D Toxicity. J Bras Nefrol. 2020;42(2):238-244.

Mei X, Zeng J, Dai WX, et al. Prevalence of hyperthyroidism with hypercalcemia in Xindu district and the efficacy of vitamin D3 treatment in these patients: a randomized trial. Ann Palliat Med.2021;10(9):9640-9.

Díaz-Roldán J, Franch-Arcas G, Ruiz-Luque V. Hypercalcemia and bulky primary adrenal non-Hodgkin lymphoma: A case report. Med Clin (Barc),2021;157(12):595-6

Gandhi A, Mortensen M, Sunny S, et al. Immobilization-induced hypercalcemia in a patient with renal failure. Endocrinol Diabetes Metab Case Rep. 2021;2021:21-0086

Ali R, Patel C. Milk-Alkali Syndrome. Free Books & Documents. PMID: 32491432 Bookshelf ID: NBK557500. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Borgan SM, Khan LZ, Makin V. Hypercalcemia and vitamin A: A vitamin to keep in mind. Cleve Clin J Med. 2022;89(2):99-105

Garam N, Tislér A, Pethő Á, et al. Hypercalcemia and renal insufficiency – where can we start? Orv Hetil.2021;162(13):514-8.

Saponaro F. Rare Causes of Hypercalcemia. Endocrinol Metab Clin North Am. 2021;50(4):769-79.

Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab.2018;103(11):3993-4004.

Khoury N, Carmichael KA. Evaluation and therapy of hypercalcemia. Mo Med 2011;108:99.

Simm PJ, Biggin A, Zacharin MR, et al. APEG Bone Mineral Working Group.Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health.2018;54(3):223-33.

LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: anunproven yet common practice. Ann Intern Med 2008; 149:259.

Walker J. Diagnosis and management of patients with hypercalcaemia. Nurs Older People. 2015;27(4):22-6.

Bhangu JS, Selberherr A, Brammen L, et al. Efficacy of calcium excretion and calcium/creatinineclearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Head Neck,2019;41(5):1372-8.

Berenson JR. Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol,2002;29(6):12-8.

Hu MI, Glezerman IG, Leboulleux S, et al. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab 2014; 99(9):3144–52.

Torres PU. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronickidney disease. J Ren Nutr 2006; 16(3):253–8.

Uludağ M, Aygün N. Primer Hiperparatiroidi: Klinik ve Biyokimyasal Bulguların Güncel Durumu. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 50, Sayı: 3, 2016 DOI: 10.5350/SEMB.20160724041035

Assadi F. Hypercalcemia: an evidence-based approach to clinical cases. Iran J Kidney Dis 2009;3: 71-9

Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment Endocr Rev. 2016; 37(5): 521–47.

Ritz E, Matthias S, Siedel A. Distributed calcium metabolism in renal failure – pathogenesis and therapeutic strategies. Kidney International 1994;37-42.

Zajı'ckova K, Dvora'kova M, Moravcová J, et al. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up Physiol Res. 2020;69:321-8.

Nazia M. Sadiq NM, Naganathan S, et al. Hypercalcemia Treasure Island (FL): StatPearls Publishing; 2022 Jan Bookshelf ID: NBK430714PMID: 28613465